In PCa, PCAT1 can negatively regulate the functional defect of BRCA2-induced homologous recombination and promote PCa cell growth through increasing cMyc; as a result, it can be used as a prognostic marker of PCa (Prensner et al., 2014). The gene discussed is MYC; the disease is posterior cortical atrophy.